| 15.11.2019 17:35:24 | |
|---|---|
| Cena | |
| 145,00 CHF | |
| Změna | 4,69% (6,50) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | SIX Swiss Exchange |
| Měna | CHF |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 370.886 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 135,40 CHF (28) |
| Prodej (částka) | 135,00 CHF (2) |
| Otevírací cena | 145,00 CHF |
| Max | 145,00 CHF |
| Min | 145,00 CHF |
| Závěrečná cena (předchozí den) | 138,50 CHF |
| Cena vážená obchodovaným objemem | 149,21 CHF |
| Objem (kusy) | - |
| Obchodovaný objem | - |
| Počet obchodů | 1 |
| Poslední zobchodovaný počet | - |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 01.12.2021 |
|
Global Equity Ratings |
|
| 05.11.2021 |
|
Global Equity Ratings |
|
| 03.11.2021 |
|
Global Equity Ratings |
|
| 19.10.2021 |
|
Global Equity Ratings |
|
| 29.09.2021 |
|
Global Equity Ratings |
|
Všechny burzy pro JOHNSON & JOHNSON
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 03.12.2021 | 17:35 | 140,98 EUR | 0,54 | 145 |
| Vienna Stock Exchange | 03.12.2021 | 17:32 | 140,84 EUR | 0,02 | 6 |
| Tradegate | 03.12.2021 | 22:26 | 140,92 EUR | 0,95 | 169 |
| Stuttgart | 03.12.2021 | 21:23 | 140,62 EUR | 0,01 | 8 |
| SIX Swiss Exchange | 15.11.2019 | 17:35 | 145,00 CHF | 0,00 | 1 |
| SIX Swiss Exchange | 30.03.2020 | 17:35 | 150,00 USD | 0,00 | 1 |
| NYSE | 03.12.2021 | 22:10 | 159,38 USD | 1.391,09 | 94.179 |
| Munich | 03.12.2021 | 17:43 | 140,84 EUR | 0,00 | 3 |
| London Stock Exchange | 03.12.2021 | 17:35 | 160,00 USD | 0,07 | 10 |
| Hanover | 03.12.2021 | 08:01 | 139,22 EUR | 0,00 | 1 |
| Hamburg | 03.12.2021 | 08:01 | 139,22 EUR | 0,00 | 1 |
| Frankfurt | 03.12.2021 | 16:12 | 139,88 EUR | 0,14 | 8 |
| Duesseldorf | 03.12.2021 | 19:31 | 140,20 EUR | 0,00 | 8 |
| Berlin | 03.12.2021 | 12:57 | 139,08 EUR | 0,00 | 2 |
| 15.11.2019 17:35:24 | |
|---|---|
| Cena | |
| 145,00 CHF | |
| Změna | 4,69% (6,50) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | SIX Swiss Exchange |
| Měna | CHF |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 370.886 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 135,40 CHF (28) |
| Prodej (částka) | 135,00 CHF (2) |
| Otevírací cena | 145,00 CHF |
| Max | 145,00 CHF |
| Min | 145,00 CHF |
| Závěrečná cena (předchozí den) | 138,50 CHF |
| Cena vážená obchodovaným objemem | 149,21 CHF |
| Objem (kusy) | - |
| Obchodovaný objem | - |
| Počet obchodů | 1 |
| Poslední zobchodovaný počet | - |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | - | - | - |
| Výkonn. (abs.) | - | - | - |
| Beta | 0,46 | 0,44 | 0,64 |
| Volatilita | - | - | 24,71 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 29,00 CHF (186.956) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 116,37 CHF (36.508) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 128,62 CHF (11.204) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 131,06 CHF (8.427) |
| YTD Max| datum | - CHF (-) |
| YTD Min | datum | - CHF (-) |
| 52týdenní max. | datum | - CHF (-) |
| 52týdenní min. | datum | - CHF (-) |
Logo společnosti
Kontakty
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon:1-732-524-0400 |
| Fax:- |
| E-mail:- |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON | |
Profil společnosti
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. |
Členové představenstva
| A. Washington | Member of Board of Directors |
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| Charles Prince | Member of Board of Directors |
| D. Davis | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Ian Davis | Member of Board of Directors |
| Jim Wennerlid | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Ronald Williams | Member of Board of Directors |
| Alex Gorsky (bis 3.01.2022) | Chairman of Managing Board |
| Peter M. Fasolo | Member of Executive Committee |
| Ashley McEvoy | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joaquin Duato (CEO ab 3.01.2022) | Member of Executive Committee |
| Joseph Wolk | Member of Executive Committee |
| Kathryn E. Wengel | Member of Executive Committee |
| Michael H. Ullmann | Member of Executive Committee |
| Michael Sneed | Member of Executive Committee |
| Paulus Stoffels, M.D. (bis 31.12.2021) | Member of Executive Committee |
| Thibaut Mongon | Member of Executive Committee |